Alvarez R - Search Results

1

Inhibitors of cyclic AMP phosphodiesterase. 4. Synthesis and evaluation of potential prodrugs of lixazinone (N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro-2- oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide, RS-82856).

Venuti MC, Alvarez R, Bruno JJ, Strosberg AM, Gu L, Chiang HS, Massey IJ, Chu N, Fried JH. Venuti MC, et al. Among authors: alvarez r. J Med Chem. 1988 Nov;31(11):2145-52. doi: 10.1021/jm00119a015. J Med Chem. 1988. PMID: 2846840

2

Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline.

Venuti MC, Stephenson RA, Alvarez R, Bruno JJ, Strosberg AM. Venuti MC, et al. Among authors: alvarez r. J Med Chem. 1988 Nov;31(11):2136-45. doi: 10.1021/jm00119a014. J Med Chem. 1988. PMID: 2846839

3

Electrochemical evaluation of the interaction between ascorbic acid and the cardiotonic drug RS-82856.

Visor GC, Lin LH, Kenley RA, Venuti MC, Alvarez R. Visor GC, et al. Among authors: alvarez r. Drug Des Deliv. 1987 Dec;2(2):121-8. Drug Des Deliv. 1987. PMID: 2855568

4

Inhibitors of cyclic AMP phosphodiesterase. 1. Analogues of cilostamide and anagrelide.

Jones GH, Venuti MC, Alvarez R, Bruno JJ, Berks AH, Prince A. Jones GH, et al. Among authors: alvarez r. J Med Chem. 1987 Feb;30(2):295-303. doi: 10.1021/jm00385a011. J Med Chem. 1987. PMID: 3027338

5

Inhibitors of cyclic AMP phosphodiesterase. 2. Structural variations of N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro- 2-oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide (RS-82856).

Venuti MC, Jones GH, Alvarez R, Bruno JJ. Venuti MC, et al. Among authors: alvarez r. J Med Chem. 1987 Feb;30(2):303-18. doi: 10.1021/jm00385a012. J Med Chem. 1987. PMID: 3027339

6

A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.

Alvarez R, Banerjee GL, Bruno JJ, Jones GL, Littschwager K, Strosberg AM, Venuti MC. Alvarez R, et al. Mol Pharmacol. 1986 Jun;29(6):554-60. Mol Pharmacol. 1986. PMID: 3012320

7

Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.

Alvarez R, Eglen RM, Chang LF, Bruno JJ, Artis DR, Kluge AF, Whiting RL. Alvarez R, et al. Prostaglandins. 1991 Aug;42(2):105-19. doi: 10.1016/0090-6980(91)90070-v. Prostaglandins. 1991. PMID: 1775633

8

RS-82856, a selective phosphodiesterase inhibitor with inotropic, afterload reduction and antithrombotic properties.

Strosberg AM, Johnson L, Montgomery W, Lee CH, Alvarez R, Bruno JJ, Jones GH, Venuti MC. Strosberg AM, et al. Among authors: alvarez r. Proc West Pharmacol Soc. 1987;30:5-10. Proc West Pharmacol Soc. 1987. PMID: 3628319 No abstract available.

9

Activation of cardiac adenylate cyclase: horminal modification of the magnesium ion requirement.

Alvarez R, Bruno JJ. Alvarez R, et al. Proc Natl Acad Sci U S A. 1977 Jan;74(1):92-5. doi: 10.1073/pnas.74.1.92. Proc Natl Acad Sci U S A. 1977. PMID: 264697 Free PMC article.

10

Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.

Alvarez R, Sette C, Yang D, Eglen RM, Wilhelm R, Shelton ER, Conti M. Alvarez R, et al. Mol Pharmacol. 1995 Oct;48(4):616-22. Mol Pharmacol. 1995. PMID: 7476886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,134 results

Search Page

Filters